View in EDS HTML Full Text PDF Full Text

Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy.

Saved in:
Bibliographic Details
Title: Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy.
Authors: Riyas Mohamed, Fathima Raahima1 (AUTHOR), Aldubaisi, Safiah1,2 (AUTHOR), Akbar, Arshiya1 (AUTHOR), Khan, Mohammad Imran2 (AUTHOR), Yaqinuddin, Ahmed1 (AUTHOR) ayaqinuddin@alfaisal.edu
Source: Cancers. Sep2025, Vol. 17 Issue 18, p2953. 29p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17182953